Table 2.
ERBB2 | ||||
---|---|---|---|---|
Mutation Type | Alteration | Count | Cases With Multiple Alterations | |
SV Only | Amplification | |||
Missense | N=181 | |||
ECD | ||||
P122L | 1 | |||
E265K | 1 | |||
G292R | 1 | |||
S310F | 19 | 6 | ||
S310Y | 8 | 1 | 1 | |
L313V | 1 | |||
TM | ||||
V659E | 1 | 1 | ||
G660D | 2 | 1 | ||
S653C | 1 | 1 | ||
JM | ||||
R678Q | 44 | 1 | 3 | |
KD | ||||
T733I | 1 | 1 | ||
L755S | 12 | 3 | 1 | |
I767M | 2 | |||
D769H | 1 | |||
D769N | 2 | |||
D769Y | 6 | 3 | 1 | |
V773M | 2 | |||
G776S | 1 | 1 | ||
G776V | 6 | |||
V777L | 19 | 2 | 9 | |
V777M | 4 | |||
V842I | 31 | 4 | 2 | |
T862A | 11 | 1 | 2 | |
H878Y | 2 | 1 | ||
R896C | 1 | |||
R896H | 1 | |||
Truncationa | N=5 | |||
A1232fs*25+ | 2 | 1 | ||
G1189fs*9 | 1 | |||
P1170fs*88+ | 1 | |||
Q1136fs*5 | 1 | |||
Indel | N=1 | |||
P780_Y781insGSP | 1 | |||
Deletion exon 16 | N=2 | |||
Splice site 1899‐59_1945del106 | 1 | |||
Deletion exon 16 | 1 |
ERBB3 | ||||
---|---|---|---|---|
Mutation Type | Alteration | Count | Cases with Multiple SV | |
Missense | N=154 | |||
ECD | ||||
M60K | 7 | 1 | ||
M91I | 1 | |||
R103H | 2 | 1 | ||
V104L | 17 | |||
V104M | 35 | 2 | ||
N126K | 1 | |||
A232V | 17 | 2 | ||
A245V | 2 | |||
R258H | 2 | |||
G284R | 26 | 1 | ||
D297Y | 14 | |||
K329E | 4 | |||
E332K | 3 | |||
T355A | 1 | |||
T355I | 1 | 1 | ||
Y464C | 1 | |||
G582V | 1 | 1 | ||
KD | N=13 | |||
S846I | 5 | 1 | ||
E928G | 8 | 2 | ||
Other | N=5 | |||
A1023T | 1 | 1 | ||
S1049G | 1 | |||
P1212S | 3 |
Abbreviations: ECD, extracellular domain; JM, juxtamembrane region; KD, kinase domain; mCRC, metastatic colorectal cancer; SV, short variant; TM, transmembrane domain.
Frameshift alterations are as follows: first amino acid and position changed, fs* to note variant type and termination codon, position of termination codon relative to first amino acid changed. A plus sign (+) indicates that no termination codon was observed in the new frame before the end of the original coding sequence.